← Back to Vaccine Database

GLS-5300

DNA based vaccine · VDDBV0303

Target & Classification

MERS-CoVMiddle east respiratory syndrome coronavirus
DNA based vaccine
MERS (Middle East Respiratory Syndrome)
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT03721718 Phase 2MERS (Middle East Respiratory Syndrome)
NCT02670187 Phase 1MERS (Middle East Respiratory Syndrome)